48 results
8-K
EX-10.1
COYA
Coya Therapeutics Inc
20 May 24
Coya Therapeutics Announces $5 Million Strategic
5:00pm
hereof (or such shorter period as the Company was required by law or regulation to file such material) (the foregoing materials, including … , pollutants, contaminants, or toxic or hazardous substances or wastes (collectively, “Hazardous Materials”) into the environment, or otherwise relating
DEFA14A
COYA
Coya Therapeutics Inc
28 Mar 24
Additional proxy soliciting materials
4:35pm
Statement
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
Definitive Proxy Statement
Definitive Additional Materials … , if Other Than the Registrant)
Payment of Filing Fee (Check all boxes that apply):
No fee required
Fee paid previously with preliminary materials
Fee
D
ds3lk388
20 Dec 23
$26.48 mm in equity / options / securities to be acquired, sold $26.48 mm, 122 investors
9:46am
8-K
EX-10.1
3oyd7y8
6 Dec 23
Entry into a Material Definitive Agreement
7:30am
8-K
EX-10.1
j7e64
14 Jul 23
Departure of Directors or Certain Officers
5:01pm
8-K
EX-10.1
qe4475w3 pcq6
10 Jul 23
Departure of Directors or Certain Officers
5:08pm
DEFA14A
h2r6qd
19 May 23
Additional proxy soliciting materials
4:39pm
DEF 14A
3ifnerj3 762cm
19 May 23
Definitive proxy
4:31pm
10-Q
mhi2gdv5k
10 May 23
Quarterly report
7:14am
10-Q
EX-10.1
omt c6asmx7uc2j
10 May 23
Quarterly report
7:14am
10-K
rmf va4baf
29 Mar 23
Annual report
4:08pm
10-K
EX-3.2
sswmyp1t
29 Mar 23
Annual report
4:08pm
424B4
faqr5h6a
30 Dec 22
Prospectus supplement with pricing info
4:17pm